Horizon Therapeutics Public Ltd Co

PNC FINANCIAL SERVICES GROUP, INC.

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/13/2023

Shares

4,429

Value ($000)

512

Weight

0.0%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/13/2023	512	0.0%	4,429	9/30/2023
2023 Q2	8/11/2023	4,618	0.0%	44,896	6/30/2023
2023 Q1	5/15/2023	5,499	0.0%	50,386	3/31/2023
2022 Q4	2/10/2023	5,514	0.0%	48,454	12/31/2022
2022 Q3	11/10/2022	3,476	0.0%	56,178	9/30/2022
2022 Q2	8/12/2022	4,704	0.0%	58,964	6/30/2022
2022 Q1	5/12/2022	1,106	0.0%	10,513	3/31/2022
2021 Q4	2/11/2022	1,196	0.0%	11,113	12/31/2021
2021 Q3	11/5/2021	1,150	0.0%	10,498	9/30/2021
2021 Q2	8/6/2021	951	0.0%	10,152	6/30/2021
2021 Q1	5/7/2021	930	0.0%	10,105	3/31/2021
2020 Q4	2/12/2021	165	0.0%	2,275	12/31/2020
2020 Q3	11/6/2020	176	0.0%	2,260	9/30/2020
2020 Q2	8/28/2020	141	0.0%	2,550	6/30/2020
2020 Q1	5/8/2020	82	0.0%	2,754	3/31/2020
2019 Q4	2/7/2020	92	0.0%	2,544	12/31/2019